Current medical treatments for juvenile idiopathic arthritis.
about
What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?Advances and challenges in imaging in juvenile idiopathic arthritis.Implementation of musculoskeletal ultrasonography in detection of early juvenile idiopathic arthritis.Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.Low pretreatment levels of myeloid-related protein-8/14 and C-reactive protein predict poor adherence to treatment with tumor necrosis factor inhibitors in juvenile idiopathic arthritis.[Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].
P2860
Current medical treatments for juvenile idiopathic arthritis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Current medical treatments for juvenile idiopathic arthritis.
@ast
Current medical treatments for juvenile idiopathic arthritis.
@en
type
label
Current medical treatments for juvenile idiopathic arthritis.
@ast
Current medical treatments for juvenile idiopathic arthritis.
@en
prefLabel
Current medical treatments for juvenile idiopathic arthritis.
@ast
Current medical treatments for juvenile idiopathic arthritis.
@en
P2860
P356
P1476
Current medical treatments for juvenile idiopathic arthritis.
@en
P2093
Alberto Martini
P2860
P356
10.3389/FPHAR.2011.00060
P577
2011-10-10T00:00:00Z